Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180‐week follow‐up results from the phase 3, multicenter IMMspire study

Saved in:
Bibliographic Details
Published inThe Journal of Dermatology Vol. 50; pp. 195 - 202
Main Authors Keiichi Yamanaka, Yukari Okubo, Ikuko Yasuda, Nobuo Saito, Izabella Messina, Akimichi Morita
Format Journal Article
LanguageJapanese
Published Wiley 13.12.2022
Subjects
Adult
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
East Asian People
Follow-Up Studies
Humans
Japan
Original Articles
Psoriasis
Severity of Illness Index
Treatment Outcome
Online AccessGet full text

Cover

More Information
ISSN:0385-2407
1346-8138
DOI:10.1111/1346-8138.16667